CNIPA.AI

Company patentsCompare

HEAD TO HEAD

China MobileHengrui Pharma

Technology portfolios compared in the same window and counting units. Scale is compared only within the same field or subclass.

Same window · published 2025-01-01 — 2025-12-31Some name or date coverage is incomplete; affected counts are lower bounds

This is a structural comparison of collected portfolios. The same requested window does not establish equal entity scope, covered months or industry; no competitive ranking is inferred.

Applicant-name coverage differs. The counts below cover only the listed names and do not represent complete company portfolios.

China Mobile: Applicant names included in these statistics — CHINA MOBILE COMM CO LTD RES INST · CHINA MOBILE COMMUNICATION CO LTD RESEARCH INST · CHINA MOBILE COMMUNICATION CO LTD RESEARCH INSTITUTE · CHINA MOBILE COMMUNICATION COMPANY LTD · CHINA MOBILE GROUP DESIGN INST · CHINA MOBILE HANGZHOU INF TECH CO LTD · CHINA MOBILE INF TECH CO LTD · CHINA MOBILE INFORMATION SYSTEM INTEGRATION CO LTD · CHINA MOBILE INTERNET CO LTD · CHINA MOBILE IOT CO LTD · CHINA MOBILE SUZHOU SOFTWARE TECH CO LTD · CHINA MOBILE SYSTEM INTEGRATION CO LTDReviewed names not covered — CHINA MOBILE (HANGZHOU) INFORMATION TECHNOLOGY COMPANY LIMITED · CHINA MOBILE (SUZHOU) SOFTWARE TECHNOLOGY CO., LTD. · CHINA MOBILE COMMUNICATION CO., LTD. · CHINA MOBILE GROUP DESIGN INSTITUTE CO., LTD. · CHINA MOBILE INFORMATION SYSTEM INTEGRATION CO., LTD. · CHINA MOBILE INFORMATION TECHNOLOGY CO., LTD. · CHINA MOBILE INTERNET COMPANY LIMITED · CHINA MOBILE IOT COMPANY LIMITED · CHINA MOBILE SYSTEM INTEGRATION CO., LTD. · 中国移动通信有限公司 · 中国移动通信集团设计院有限公司 · 中移(苏州)软件技术有限公司 · 中移互联网有限公司 · 中移信息系统集成有限公司 · 中移动信息技术有限公司 · 中移物联网有限公司 · 中移系统集成有限公司 · 中移(杭州)信息技术有限公司

Hengrui Pharma: Applicant names included in these statistics — JIANGSU HENGRUI MEDICINE CO · JIANGSU HENGRUI MEDICINE CO LTD · JIANGSU HENGRUI PHARMACEUTICALS CO LTDReviewed names not covered — JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. · 江苏恒瑞医药股份有限公司

Publications
2,808
Invention share
95%
Concentration
0.49
Green technology
—
Publications
618
Invention share
66%
Concentration
1.23
Green technology
—
0.00Field similarity
Cosine similarity of application counts across 35 fields. 1 is identical, 0 is no overlap.

01Technology field mirror

The 12 fields with the largest combined share. Share shows structure; count shows scale.

Technology field mirror
China MobileTechnology fieldHengrui Pharma
0%
Pharmaceuticals
93%
51.5%
Digital communication
0%
0%
Organic fine chemistry
49.7%
47.1%
Computer technology
0%
0%
Biotechnology
34.3%
5.4%
Telecommunications
0%
5.1%
IT methods for management
0%
2.8%
Audio-visual technology
0%
0%
Analysis of biological materials
2%
1.4%
Measurement
0.5%
1.7%
Control
0%
0.9%
Electrical machinery, apparatus, energy
0%

Inspect one technology field

Inspect collected applications, portfolio share and supporting publications within one field. A technology overlap does not establish that companies in different industries are direct competitors.

One application may belong to multiple fields, so shares can sum to more than 100%. Drill-down lists publications; an application publication and its grant may appear separately.

02Same problem: shared IPC subclasses

The 10 subclasses in every company's top 60 with the most combined applications. Scale is compared within a subclass, never across different business scopes.

G01NAnalysing materials
China Mobile5
Hengrui Pharma14

03Where each one leans

Observed emphasis within each company’s collected top-60 IPC subclasses. A dash for another company means outside its top-60 list, not zero applications or a market gap. Incomplete coverage can also change the ordering.

China Mobile

  • G06FData processing
    China Mobile
    1,025
    Hengrui Pharma
    —
  • H04LDigital transmission
    China Mobile
    839
    Hengrui Pharma
    —
  • H04WWireless networks
    China Mobile
    700
    Hengrui Pharma
    —
  • G06NComputing models, AI
    China Mobile
    540
    Hengrui Pharma
    —
  • G06VImage and video recognition
    China Mobile
    163
    Hengrui Pharma
    —
  • G06QBusiness data processing
    China Mobile
    142
    Hengrui Pharma
    —

Hengrui Pharma

  • A61K
    China Mobile
    —
    Hengrui Pharma
    539
  • A61P
    China Mobile
    —
    Hengrui Pharma
    504
  • C07DHeterocyclic compounds
    China Mobile
    —
    Hengrui Pharma
    270
  • C07K
    China Mobile
    —
    Hengrui Pharma
    196
  • C12NMicroorganisms, enzymes
    China Mobile
    —
    Hengrui Pharma
    70
  • C07C
    China Mobile
    —
    Hengrui Pharma
    45

04Publication rhythm

China MobileHengrui PharmaPublications per period
Publications per period
PeriodChina MobileHengrui Pharma
2025-01≥257 (partial coverage)≥33 (partial coverage)
2025-02≥275 (partial coverage)≥41 (partial coverage)
2025-03≥212 (partial coverage)≥82 (partial coverage)
2025-04≥209 (partial coverage)≥52 (partial coverage)
2025-05≥268 (partial coverage)≥61 (partial coverage)
2025-06≥128 (partial coverage)≥50 (partial coverage)
2025-07≥160 (partial coverage)≥57 (partial coverage)
2025-08≥203 (partial coverage)≥44 (partial coverage)
2025-09≥168 (partial coverage)≥51 (partial coverage)
2025-10≥323 (partial coverage)≥47 (partial coverage)
2025-11≥159 (partial coverage)≥50 (partial coverage)
2025-12≥446 (partial coverage)≥50 (partial coverage)

Empty dashed outlines mark uncollected periods. Hatched bars and ≥ counts mark partial coverage.

Publication timing follows examination and publication cycles, not R&D intensity.

What makes it comparableThe same publication window and counting units. Companies with different windows are not put in one comparison.

What is not comparableGroup totals. Business and entity scopes differ; compare scale within a field or subclass.

Not a rankingSimilarity and shares describe structure, not patent value, quality or technical leadership.